NAS:BBIO (USA) Also Trade In: Germany

BridgeBio Pharma Inc $ 67.23 1.29 (1.96%)

Volume:
321,055
Avg Vol (1m):
1,037,071
Market Cap $:
10.03 Bil
Enterprise Value $:
9.85 Bil
PE Ratio:
0.00
PB Ratio:
48.64
Warning! GuruFocus has detected 1 Severe warning sign with BBIO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

4/10
Current Vs Industry Vs History
Cash-To-Debt 1.47
Equity-to-Asset 0.21
Debt-to-Equity 2.95
Debt-to-EBITDA -1.14
N/A
Altman Z-Score 8.19
DISTRESS
GREY
SAFE
WACC vs ROIC
ROIC -539.28 %
WACC 7.4 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -1939.45
Net Margin % -1832.68
ROE % -119.81
ROA % -50.85
ROC (Joel Greenblatt) % -2502.74

Valuation Rank

Current Vs Industry Vs History
PB Ratio 48.64
PS Ratio 362.31
EV-to-EBIT -23.14
N/A
EV-to-EBITDA -23.14
N/A
EV-to-Revenue 448.91
Current Ratio 9.85
Quick Ratio 9.85
Days Payable 1436.49

Dividend & Buy Back

Current Vs Industry Vs History

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 48.48
Earnings Yield (Greenblatt) % -4.32